Prevalence Estimate Chlamydia and Gonorrhoea Netherlands

Completed

• Conditions: Gonorroe; Sexually Transmitted Infections; STI; 10008555

• Registration Number: NL-OMON43464
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 3100

Inclusion Criteria

age 18-34 years

Exclusion Criteria

age below 18 years or above 34 years; no sexual experience (no experience with sexual intercourse)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Proportion chlamydia and gonorrhoea positive among participants and estimates<br /><br>thereof for the entire population and by risk factor / subgroup (or<br /><br>combinations thereof).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- To evaluate the validity of current surveillance data, by getting better<br /><br>insight into the prevalence and risk factors among the population groups<br /><br>visiting the general practice or STI clinic for STI testing and those who do<br /><br>not seek STI Healthcare (but have been at risk for STI).<br /><br>- Gain better insight into the factors (demographic and behavioral) associated<br /><br>with STIs in the Netherlands.<br /><br>- To obtain data that can serve as input for transmission models in the<br /><br>Netherlands to predict the impact of interventions.</p><br>